Susana Monge

3.2k total citations
82 papers, 1.3k citations indexed

About

Susana Monge is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Susana Monge has authored 82 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Infectious Diseases, 34 papers in Epidemiology and 15 papers in Emergency Medicine. Recurrent topics in Susana Monge's work include HIV/AIDS Research and Interventions (16 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and HIV Research and Treatment (12 papers). Susana Monge is often cited by papers focused on HIV/AIDS Research and Interventions (16 papers), SARS-CoV-2 and COVID-19 Research (12 papers) and HIV Research and Treatment (12 papers). Susana Monge collaborates with scholars based in Spain, Sweden and Netherlands. Susana Monge's co-authors include Julia del Amo, Débora Álvarez-del Arco, Teymur Noori, Belén Alejos, Miguel A. Hernán, Víctoria Hernando, Andrew J. Amato‐Gauci, Anastasia Pharris, Fiona Burns and Ibidun Fakoya and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The Science of The Total Environment.

In The Last Decade

Susana Monge

70 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Susana Monge Spain 20 740 500 222 212 157 82 1.3k
Demetre Daskalakis United States 26 1.2k 1.6× 823 1.6× 294 1.3× 368 1.7× 93 0.6× 66 1.8k
Alain Vandormael South Africa 21 691 0.9× 473 0.9× 171 0.8× 163 0.8× 63 0.4× 63 1.3k
Trang Nguyen United States 19 566 0.8× 471 0.9× 149 0.7× 225 1.1× 76 0.5× 65 1.2k
Christy M. Anderson United States 21 509 0.7× 498 1.0× 131 0.6× 421 2.0× 36 0.2× 44 1.3k
Ngai Sze Wong Hong Kong 18 555 0.8× 521 1.0× 125 0.6× 139 0.7× 70 0.4× 108 993
Tarylee Reddy South Africa 22 664 0.9× 393 0.8× 105 0.5× 190 0.9× 58 0.4× 122 1.3k
Meaghan Kall United Kingdom 18 979 1.3× 662 1.3× 147 0.7× 197 0.9× 110 0.7× 48 1.3k
Minh D. Pham Australia 18 441 0.6× 297 0.6× 89 0.4× 139 0.7× 195 1.2× 49 1.5k
Keren Middelkoop South Africa 27 1.8k 2.4× 1.3k 2.7× 149 0.7× 170 0.8× 61 0.4× 64 2.2k
Anneli Uusküla Estonia 27 1.1k 1.4× 1.4k 2.8× 375 1.7× 226 1.1× 105 0.7× 154 2.3k

Countries citing papers authored by Susana Monge

Since Specialization
Citations

This map shows the geographic impact of Susana Monge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Susana Monge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Susana Monge more than expected).

Fields of papers citing papers by Susana Monge

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Susana Monge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Susana Monge. The network helps show where Susana Monge may publish in the future.

Co-authorship network of co-authors of Susana Monge

This figure shows the co-authorship network connecting the top 25 collaborators of Susana Monge. A scholar is included among the top collaborators of Susana Monge based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Susana Monge. Susana Monge is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Pastor‐Barriuso, Roberto, et al.. (2025). Infants needed to immunise with nirsevimab to prevent one RSV hospitalisation, Spain, 2023/24 season. Eurosurveillance. 30(6). 1 indexed citations
3.
4.
Sánchez, Elena Vanessa Martínez, et al.. (2025). Fallecimientos por COVID-19: comparación entre datos de vigilancia epidemiológica y del Instituto Nacional de Estadística. Gaceta Sanitaria. 39. 102523–102523.
5.
Colombe, Soledad, Anders Koch, Manon Haverkate, et al.. (2024). Effectiveness of historical smallpox vaccination against mpox clade II in men in Denmark, France, the Netherlands and Spain, 2022. Eurosurveillance. 29(34). 3 indexed citations
6.
Mazagatos, Clara, Jacobo Mendioroz, Olaia Pérez‐Martínez, et al.. (2024). Estimated Impact of Nirsevimab on the Incidence of Respiratory Syncytial Virus Infections Requiring Hospital Admission in Children < 1 Year, Weeks 40, 2023, to 8, 2024, Spain. Influenza and Other Respiratory Viruses. 18(5). e13294–e13294. 13 indexed citations
7.
Mazagatos, Clara, et al.. (2024). Epidemiología y carga de enfermedad por VRS en España. SiVIRA, temporadas 2021-22 y 2022-23. 32(1). 21–35. 3 indexed citations
9.
Gómez‐Barroso, Diana, Concepción Delgado‐Sanz, Susana Monge, et al.. (2024). Estimación de la incidencia real de la COVID-19 en España. SHILAP Revista de lepidopterología. 7–14. 1 indexed citations
10.
Monge, Susana, Roberto Pastor‐Barriuso, & Miguel A. Hernán. (2023). The imprinting effect of covid-19 vaccines: an expected selection bias in observational studies. BMJ. 381. e074404–e074404. 20 indexed citations
11.
Vega‐Piris, Lorena, Elena Vanessa Martínez Sánchez, Clara Mazagatos, et al.. (2022). Comparative severity of COVID-19 cases caused by Alpha, Delta or Omicron SARS-CoV-2 variants and its association with vaccination. Enfermedades Infecciosas y Microbiología Clínica. 42(4). 187–194. 6 indexed citations
12.
Monge, Susana, et al.. (2020). PND56 Cost-Effectiveness of Erenumab for the Prevention of Migraine in Portugal. Value in Health. 23. S633–S633.
14.
Monge, Susana, Kimberley Benschop, Loes Soetens, et al.. (2018). Echovirus type 6 transmission clusters and the role of environmental surveillance in early warning, the Netherlands, 2007 to 2016. Eurosurveillance. 23(45). 12 indexed citations
15.
Fakoya, Ibidun, Débora Álvarez-del Arco, Susana Monge, et al.. (2016). Advancing Migrant Access to Health Services in Europe (AMASE): Protocol for a Cross-sectional Study. JMIR Research Protocols. 5(2). e74–e74. 16 indexed citations
16.
Monge, Susana & José A. Pérez‐Molina. (2016). Infección por el VIH e inmigración. Enfermedades Infecciosas y Microbiología Clínica. 34(7). 431–438. 5 indexed citations
17.
Monge, Susana, María José Díez, José Antonio Iribarren, et al.. (2014). Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007–2012). Clinical Microbiology and Infection. 21(1). 105.e1–105.e5. 8 indexed citations
18.
Fakoya, Ibidun, Débora Álvarez-del Arco, Alison Brown, et al.. (2013). Migrant Health: Sexual transmission of HIV within migrant groups in the EU/EEA and implications for effective interventions. UCL Discovery (University College London). 23 indexed citations
19.
Hernando, Víctoria, Belén Alejos, Susana Monge, et al.. (2013). All-cause mortality in the cohorts of the Spanish AIDS Research Network (RIS) compared with the general population: 1997–2010. BMC Infectious Diseases. 13(1). 382–382. 15 indexed citations
20.
Arco, Débora Álvarez-del, Susana Monge, Amaya Azcoaga-Lorenzo, et al.. (2012). HIV testing and counselling for migrant populations living in high-income countries: a systematic review. European Journal of Public Health. 23(6). 1039–1045. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026